KPV (Lysine-Proline-Valine)

What Is KPV?

KPV is a naturally occurring tripeptide composed of lysine, proline, and valine. It corresponds to the terminal three-amino-acid sequence of alpha-melanocyte-stimulating hormone (alpha-MSH) and is often described as an alpha-MSH fragment.

Preclinical research has explored potential anti-inflammatory and immune modulation effects of KPV peptide. However, human clinical evidence remains limited, and it is not an established treatment for inflammatory or autoimmune conditions. Dr. Bird can help you explore this option as part of a broader treatment plan for your specific needs.

Available Forms of KPV Peptide

KPV peptide therapy may include:

• KPV cream for potential skin healing and inflammatory skin concerns
• Oral KPV peptide studied for gut health, colitis, and inflammatory bowel disease
• Injectable KPV used in physician-supervised protocols

The appropriate form and KPV dosage depend on your health history and treatment goals.

Clinical Uses of KPV Peptide Therapy

Here are the key potential functions of this naturally occurring tripeptide, which is used in different peptide therapy protocols.

Anti-Inflammatory Research

Preclinical evidence suggests that KPV may influence cellular pathways associated with inflammation. Laboratory studies have examined how this tripeptide interacts with inflammatory signaling and immune responses.

Inactivating Inflammatory Pathways Inside Cells

KPV exerts its anti-inflammatory function inside cells, where it inactivates inflammatory pathways. KPV can enter the cell and interact directly with inflammatory signaling molecules. It enters the nucleus of the cell, and once it’s there, it can inhibit inflammatory substances and molecules.

Reducing Inflammation in Gut and Immune Cells

KPV peptides can stop the proinflammatory mechanisms in both intestinal epithelial cells and immune cells. It can interact directly with immune cells, which can reduce inflammation and support gut health, particularly in conditions like colitis and IBD.

Inhibition of Proinflammatory Cytokines

Taken orally, KPV decreases the synthesis and secretion of proinflammatory cytokines that drive inflammation. This function of oral KPV peptides lowers the overall inflammatory responses, reducing the incidence and severity of colitis and other inflammatory conditions.

Anti-Microbial

KPV peptides also have anti-microbial effects against pathogens. Its anti-microbial effects were demonstrated on two major pathogens: S. aureus and C. albicans. In one study, this tripeptide significantly inhibited S. aureus from forming colonies.

KPV cream, with its anti-inflammatory and anti-microbial properties, can be very helpful for combating these microbes and healing wounds.

Wound Healing/Skin

Research on skin healing shows KPV can speed wound healing, reduce infection, fight inflammation, and lead to better cosmetic results. These benefits occur at physiologic concentrations, suggesting that KPV could help prevent infection in cases of serious wounds like burns.

Keloid Prevention

KPV peptides are able to reduce the type of inflammation that leads to the formation of hypertrophic scars (keloids). Administering KPV (a-MSH) in this setting leads to smaller scars and a less drastic inflammatory response.

Part of the benefit in reducing scar prominence appears to come from its ability to modulate collagen metabolism.

Psoriasis Support

KPV cream has significant anti-microbial and anti-inflammatory properties, especially in those with psoriasis. Psoriasis is a chronic autoimmune condition that causes the rapid build-up of skin cells and is usually treated using hydrocortisone.

In people with psoriasis, KPV has been shown to limit symptoms of the condition, including itchiness, dryness, redness, peeling, and more. Therefore, KPV could be used for an extended period of time without risking the unwanted complications of long-term steroid therapy.

Potential Benefits of KPV

Areas being explored in research include:

• Anti-inflammatory signaling pathways
• Immune modulation
• Gut health support
• Skin healing and wound response
• Laboratory antimicrobial activity

Frequently Asked Questions About KPV Treatment

How is KPV administered?

KPV can be administered in different dosages in topical, oral, or subcutaneous/intramuscular injectable forms. KPV creams are ideal for skin healing and wound healing, while oral KPV peptides support systemic inflammation and injectables provide targeted therapy.

What is KPV used for?

KPV is a potent anti-inflammatory peptide with a host of benefits, including accelerating wound healing, reducing infection, fighting inflammation, and improving gut conditions such as IBD and colitis.

Is KPV safe?

Human safety data for KPV peptide therapy are limited. Risks, side effects, and long-term outcomes are not fully established and may vary by formulation and dosage.

Patients should consult a qualified provider before starting any peptide therapy.

Do I need to visit in person for KPV therapy?

Patients in the Phoenix metro area can visit TransformYou in person for evaluation and treatment with Dr. Robb Bird. Depending on the clinical protocol, care may also be coordinated through telehealth for eligible patients, with physician oversight throughout the process.

Explore Personalized KPV Peptide Treatment Options at TransformYou

Ready to start KPV therapy? At TransformYou, we offer personalized injections, KPV creams, and oral KPV peptides, all under physician supervision. As a regulated peptide provider with 18 years of clinical expertise, our team provides safe, evidence-based hormone optimization solutions to support your health.

Schedule a consultation today to learn how our physician-led approach can help you explore the potential benefits of KPV peptide therapy.

Request an Appointment

Research

1. Luger TA, Brzoska T. alpha-MSH related peptides: a new class of anti-inflammatory and immunomodulating drugs. Ann Rheum Dis. 2007;66 Suppl 3(Suppl 3):iii52-iii55. doi:10.1136/ard.2007.079780
2. Dalmasso, G., et al. (2008). PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation. Gastroenterology, 134(1), 166–178. DOI: 10.1053/j.gastro.2007.10.026
3. Rajora N, Boccoli G, Catania A, et al. α-MSH modulates experimental inflammatory bowel disease. Peptides. 1997;18:381–385.
4. Brzoska T, Luger TA, Maaser C, Abels C, Böhm M. Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, anti-inflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases. Endocr Rev. 2008 Aug;29(5):581-602. doi: 10.1210/er.2007-0027. Epub 2008 Jul 8. PMID: 18612139.
5. Brzoska T, Böhm M, Lügering A, Loser K, Luger TA. Terminal signal: anti-inflammatory effects of α-melanocyte-stimulating hormone related peptides beyond the pharmacophore. Adv Exp Med Biol. 2010;681:107-16. doi: 10.1007/978-1-4419-6354-3_8. PMID: 21222263.
6. Luger TA, Bohm M. Are melanocortin peptides future therapeutics for cutaneous wound healing? Experimental Derm. 20 January 2019. https://doi.org/10.1111/exd.13887
7. Elliott R J, Szabo M, Wagner M J, Kemp E H, MacNeil S, Haycock J W. alpha‐Melanocyte‐stimulating hormone, MSH 11‐13 KPV and adrenocorticotropic hormone signaling in human keratinocyte cells. J Invest Dermatol 20041221010–1019.
8. Sarkar A, Sreenivasan Y, Manna SK 2003. α-Melanocyte-stimulating hormone induces cell death in mast cells: involvement of NF-κB. FEBS Lett 549:87–93.
9. Redondo P, García-foncillas J, Okroujnov I, Bandrés E. Alpha-MSH regulates interleukin-10 expression by human keratinocytes. Arch Dermatol Res. 1998;290(8):425-8.
10. Mehta D, Granstein R, D: Immunoregulatory Effects of Neuropeptides on Endothelial Cells: Relevance to Dermatological Disorders. Dermatology 2019;235:175-186. doi: 10.1159/000496538
11. Sinha PS, Schiöth HB, Tatro JB. Roles of the melanocortin-4 receptor in antipyretic and hyperthermic actions of centrally administered alpha-MSH. Brain Res. 2004;1001(1-2):150-8
12. Taylor AW, Yee DG, Nishida T, Namba K. Neuropeptide regulation of immunity. The immunosuppressive activity of alpha-melanocyte-stimulating hormone (alpha-MSH). Ann N Y Acad Sci. 2000;917:239-47
13. Van de meent H, Hamers FP, Lankhorst AJ, Joosten EA, Gispen WH. Beneficial effects of the melanocortin alpha-melanocyte-stimulating hormone on clinical and neurophysiological recovery after experimental spinal cord injury. Neurosurgery. 1997;40(1):122-30
14. Abdel-malek ZA, Kadekaro AL, Kavanagh RJ, et al. Melanoma prevention strategy based on using tetrapeptide alpha-MSH analogs that protect human melanocytes from UV-induced DNA damage and cytotoxicity. FASEB J. 2006;20(9):1561-3
15. Bohm M, Wolff I, Scholzen TE, et al. alpha-Melanocyte-stimulating hormone protects from ultraviolet radiation-induced apoptosis and DNA damage. J Biol Chem. 2005;280(7):5795-802
16. Lam C W, Getting S J. Melanocortin receptor type 3 as a potential target for anti‐inflammatory therapy. Curr Drug Targets Inflamm Allergy 20043311–315.